Regulation of the Antibody Response to Type III Pneumococcal Polysaccharide

Open Access
Publisher Website
Google Scholar
Abstract
The present study was conducted primarily to obtain information concerning the mechanism by which suppressor thymic-derived (T) cells influence the magnitude of the antibody response to type III pneumococcal polysaccharide (SSS-III). This was accomplished by examining the effects of treatment with antilymphocyte serum (ALS) and Velban, a mitotic inhibitor, on the kinetics for the appearance of plaque-forming cells (PFC) in mice immunized with SSS-III. Without ALS-treatment, the kinetics were essentially biphasic. First, there was a phase during which PFC appeared at a relatively rapid rate; this was followed by a phase during which the rate of appearance of PFC gradually declined until maximal numbers were attained. In contrast, similar rate changes were not noted for mice given ALS; here, PFC increased at a uniform exponential rate throughout the 1st 5 days of the antibody response. Velban completely arrested the development of additional PFC in ALS-treated but not non-ALS-treated mice. These findings indicate that suppressor T cells act primarily by limiting the extent to which antibody-forming bone marrow-derived cells proliferate following immunization.

This publication has 0 references indexed in Scilit: